Hudson Executive Capital LP Insider Trading $EGRX EAGLE PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Hudson Executive Capital LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Hudson Executive Capital LP. Hudson Executive Capital LP is 10% Owner in TIVITY HEALTH, INC. ($TVTY) and 10% Owner in USA TECHNOLOGIES INC ($USAT) and Director in USA TECHNOLOGIES INC ($USAT) and Director in EAGLE PHARMACEUTICALS, INC. ($EGRX) and 10% Owner in Corindus Vascular Robotics, Inc. ($CVRS) and 10% Owner in Cardtronics plc ($CATM) and Director in Cardtronics plc ($CATM).
Hudson Executive Capital LP in EAGLE PHARMACEUTICALS, INC.
Trading Symbol: EGRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Hudson Executive Capital LP: Director
Holdings: 748,214 shares
Current Value: $51,955,980
Latest Transaction: Oct 28 2019
$EGRX Market Capitalization: $1.09B
$EGRX Previous Close: $69.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Hudson Executive Capital LP in EAGLE PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, USAT, CATM, CVRS, EGRX, TVTY
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 28 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 63.57 | 15,437 | 981,302 | 732,777 | 748.2 K to 732.8 K (-2.06 %) |
Oct 28 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 63.57 | 15,437 | 981,302 | 732,777 | 748.2 K to 732.8 K (-2.06 %) |
Oct 28 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 62.53 | 1,494 | 93,412 | 748,214 | 749.7 K to 748.2 K (-0.20 %) |
Oct 28 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 62.53 | 1,494 | 93,412 | 748,214 | 749.7 K to 748.2 K (-0.20 %) |
Oct 23 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 62.58 | 200 | 12,516 | 749,708 | 749.9 K to 749.7 K (-0.03 %) |
Oct 23 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 62.58 | 200 | 12,516 | 749,708 | 749.9 K to 749.7 K (-0.03 %) |
Oct 23 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 62.68 | 6,567 | 411,618 | 749,908 | 756.5 K to 749.9 K (-0.87 %) |
Oct 23 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 62.68 | 6,567 | 411,618 | 749,908 | 756.5 K to 749.9 K (-0.87 %) |
Oct 23 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 62.56 | 3,849 | 240,791 | 756,475 | 760.3 K to 756.5 K (-0.51 %) |
Oct 23 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 62.56 | 3,849 | 240,791 | 756,475 | 760.3 K to 756.5 K (-0.51 %) |
Oct 18 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 62.61 | 1,600 | 100,174 | 760,324 | 761.9 K to 760.3 K (-0.21 %) |
Oct 18 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 62.58 | 13,842 | 866,196 | 761,924 | 775.8 K to 761.9 K (-1.78 %) |
Oct 18 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 62.50 | 102 | 6,375 | 775,766 | 775.9 K to 775.8 K (-0.01 %) |
Oct 15 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 62.63 | 3,909 | 244,836 | 775,868 | 779.8 K to 775.9 K (-0.50 %) |
Oct 15 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 60.39 | 16,300 | 984,419 | 779,777 | 796.1 K to 779.8 K (-2.05 %) |
Oct 15 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 60.16 | 7,829 | 471,002 | 796,077 | 803.9 K to 796.1 K (-0.97 %) |
Oct 09 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 60.03 | 1,558 | 93,520 | 803,906 | 805.5 K to 803.9 K (-0.19 %) |
Oct 09 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 60.11 | 4,901 | 294,600 | 805,464 | 810.4 K to 805.5 K (-0.60 %) |
Sep 19 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 60.00 | 100 | 6,000 | 810,365 | 810.5 K to 810.4 K (-0.01 %) |
Sep 13 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 60.07 | 200 | 12,014 | 810,465 | 810.7 K to 810.5 K (-0.02 %) |
Sep 13 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 60.07 | 200 | 12,014 | 810,465 | 810.7 K to 810.5 K (-0.02 %) |
Sep 13 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 60.06 | 1,112 | 66,785 | 810,665 | 811.8 K to 810.7 K (-0.14 %) |
Sep 13 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hudson Executive Capital LP | Director | Sell | S | 60.06 | 1,112 | 66,785 | 810,665 | 811.8 K to 810.7 K (-0.14 %) |
Page: 1